✦ LIBER ✦

Prevention of vascular events in patients with cerebrovascular disease: Efficacy and appropriate duration of antiplatelet therapy

✍ Scribed by Gabriel B. Habib SR.

Book ID: 112066443
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 34 KB
Volume: 29
Category: Article
ISSN: 0160-9289
DOI: 10.1002/clc.4960290604

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiplatelet therapy for the primary and

Antiplatelet therapy for the primary and secondary prevention of cerebrovascular events in patients with extracranial carotid artery disease

✍ Thomas J. Kiernan; Bryan P. Yan; Michael R. Jaff 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 232 KB

Value of Antiplatelet Therapy in Prevent

Value of Antiplatelet Therapy in Preventing Thrombotic Events in Generalized Vascular Disease

✍ G. Montalescot 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 582 KB

Review and management of side effects as

Review and management of side effects associated with antiplatelet therapy for prevention of recurrent cerebrovascular events

✍ Robert Guthrie 📂 Article 📅 2011 🏛 Springer Healthcare Communications 🌐 English ⚖ 664 KB

Antiplatelet Agents in the Prevention of

Antiplatelet Agents in the Prevention of Cardiovascular Morbidity and Mortality in Older Patients With Vascular Disease

✍ Aronow, Wilbert S. 📂 Article 📅 1999 🏛 Springer International Publishing AG 🌐 English ⚖ 160 KB

Ticagrelor, a New Antiplatelet Agent, fo

Ticagrelor, a New Antiplatelet Agent, for Prevention of Ischemic Events in Patients with Coronary Artery Disease

✍ Harold P. Adams 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 64 KB

Primary Prevention of Major Cardiovascul

Primary Prevention of Major Cardiovascular and Cerebrovascular Events with Statins in Diabetic Patients

✍ Folgerdiena M. de Vries BSc, Petra Denig, Koen B. Pouwels, Maarten J. Postma, Ee 📂 Article 📅 2012 🏛 Springer International Publishing AG 🌐 English ⚖ 164 KB